Global Ketorolac Injection Competitive Landscape Professional Research Report 2025

Global Ketorolac Injection Competitive Landscape Professional Research Report 2025

Research Summary

Ketorolac injection is a nonsteroidal anti-inflammatory drug (NSAID) used for the short-term relief of moderate to severe pain. It is often administered intramuscularly or intravenously in hospital or clinical settings. Ketorolac works by inhibiting the production of prostaglandins, which are chemicals involved in inflammation. This medication is particularly useful in situations where oral administration may not be feasible, and rapid pain relief is required, such as postoperative pain, kidney stone pain, or pain related to certain medical procedures. While ketorolac injection provides effective pain management, it is essential to use it for the shortest duration possible due to the potential risks associated with NSAIDs, including gastrointestinal bleeding and kidney problems. As with any medication, it should be prescribed and administered under the guidance of a healthcare professional.

According to DIResearch's in-depth investigation and research, the global Ketorolac Injection market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Ketorolac Injection include Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma), Sagent Pharmaceuticals, Hikma, Lunan Pharma, Alvogen, Chengdu Brilliant Pharmaceuticals, Athenex, Sichuan Medcalo, Julphar Bangladesh Ltd., Yung Shin Pharm, Tianjin Chase Sun Pharmaceutical, ZISKA Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Ketorolac Injection. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Ketorolac Injection market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Ketorolac Injection market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Ketorolac Injection industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Ketorolac Injection Include:

Pfizer

Fresenius Kabi

Fosun Pharma (Gland Pharma)

Sagent Pharmaceuticals

Hikma

Lunan Pharma

Alvogen

Chengdu Brilliant Pharmaceuticals

Athenex

Sichuan Medcalo

Julphar Bangladesh Ltd.

Yung Shin Pharm

Tianjin Chase Sun Pharmaceutical

ZISKA Pharmaceuticals

Ketorolac Injection Product Segment Include:

Ketorolac Injection 15mg/ml

Ketorolac Injection 30mg/ml

Ketorolac Injection Product Application Include:

Hospital

Clinics

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Ketorolac Injection Industry PESTEL Analysis

Chapter 3: Global Ketorolac Injection Industry Porter’s Five Forces Analysis

Chapter 4: Global Ketorolac Injection Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Ketorolac Injection Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Ketorolac Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Ketorolac Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Ketorolac Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Ketorolac Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Ketorolac Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Ketorolac Injection Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Ketorolac Injection Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources